Roberts S J, Harris C M
Prescribing Research Unit, University of Leeds.
BMJ. 1993 Aug 21;307(6902):485-8. doi: 10.1136/bmj.307.6902.485.
To derive demographic weightings to replace the existing system of prescribing units used in analysing prescribing by general practitioners in England.
The prescribing data for one year from a sample of 90 practices in 80 family health service authority areas were used to calculate the relative frequency with which items were prescribed, for each sex, in nine age bands and for temporary residents. Data on the variation in cost per item by age and sex then allowed estimates to be made of the relative costs for these groups. Integer values for both the item based and cost based weightings were obtained by conversion to optimal integer scales.
Item based and cost based weightings for each of the 18 age-sex groups and for temporary residents. The cost based weightings were considered more appropriate to the context in which the new system was to be used.
Prescribing costs increased noticeably, for both sexes, in the middle years (ages 35-64). Compared with the existing system, the cost based weightings (ASTRO-PUs) gave greater weight to patients aged 45 and over, especially those in the 55-64 age band, at the expense of younger patients. Children under 5 received twice as many items as those aged 5-14, but the inexpensiveness of their drugs made the cost based weightings of the two groups equal. Similarly, women were generally given more items than men, but at a lower average cost per item, which reduced differences between the sexes in the cost based weightings. Costs for patients aged 75 and over, compared with those aged 65-74, were higher only for women.
The cost based weightings proposed are believed to reflect the present distribution of prescribing costs, in relation to age and sex, in English general practice. They are intended for use in analyses at practice level.
得出人口加权值,以取代英格兰全科医生处方分析中使用的现有处方单位系统。
采用来自80个家庭健康服务管理局辖区内90家诊所一年的处方数据,计算各年龄段、按性别以及临时居民中各项药物的处方相对频率。然后根据年龄和性别计算每项药物的成本差异,从而估算这些群体的相对成本。通过转换为最优整数标度,得出基于项目和基于成本的加权值的整数值。
18个年龄-性别组以及临时居民的基于项目和基于成本的加权值。基于成本的加权值被认为更适合新系统的应用场景。
中年时期(35-64岁),无论男性还是女性,处方成本均显著增加。与现有系统相比,基于成本的加权值(ASTRO-PUs)给予45岁及以上患者更大权重,尤其是55-64岁年龄段的患者,而年轻患者的权重相应降低。5岁以下儿童的处方数量是5-14岁儿童的两倍,但由于其药物成本较低,两组基于成本的加权值相等。同样,女性的处方数量通常多于男性,但每项的平均成本较低,这缩小了基于成本的加权值中两性之间的差异。75岁及以上女性患者的成本与65-74岁女性患者相比,仅在女性中较高。
所提出的基于成本的加权值被认为反映了英格兰全科医疗中目前按年龄和性别划分的处方成本分布情况。它们旨在用于诊所层面的分析。